Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2012, Article ID 362085, 12 pages
http://dx.doi.org/10.1155/2012/362085
Review Article

Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword

1Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
2Pulmonary and Critical Care Section, Department of Medicine, Denver Veterans Affairs Medical Center, Denver, CO 80220, USA
3Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
4Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado, Anschutz Medical Campus, C-281 12700 East 19th Avenue, Aurora, CO 80045, USA

Received 29 February 2012; Accepted 9 July 2012

Academic Editor: Andrea Galli

Copyright © 2012 Howard Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Howard Li, Mary C. M. Weiser-Evans, and Raphael Nemenoff, “Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword,” PPAR Research, vol. 2012, Article ID 362085, 12 pages, 2012. https://doi.org/10.1155/2012/362085.